natgillin/translations-raw huggingface dataset:
problems with your heart or circulatory system as there is only limited experience in patients with serious problems of this type.
probleme sa srcem ili cirkulacijom, obzirom da su iskustva kod bolesnika s ozbiljnim problemima ove vrste ograničena.
Problems with your heartbeat such as fast or slow heartbeat
Problemi s radom srca, poput ubrzanih ili usporenih otkucaja srca
Problems with your heartbeat such as slow heartbeat
Problemi s radom srca, poput ubrzanih ili usporenih otkucaja srca
Problems with your liver (elevated transaminases, hyperbilirubinemia);
problemi s jetrom (povišene transaminaze, hiperbilirubinemija);
problems with your liver including chronic hepatitis B or C as there is only limited experience in patients with liver problems.
probleme s jetrom uključujući kronični hepatitis B ili C, budući da su iskustva s primjenom ovog lijeka u bolesnika s bolestima jetre ograničena.
Problems with your lungs such as breathing difficulties or cough.
plućne tegobe, poput otežana disanja ili kašlja.
Problems with your nerves – you may notice numbness, tingling or burning in your hands, feet, legs or arms, reduced sensation or weakness with movement (peripheral neuropathy).
Problemi s vašim živcima – mogli biste primijetiti utrnulost, trnce ili žarenje u šakama, stopalima, nogama ili rukama, smanjen osjet ili slabost prilikom pokreta (periferna neuropatija).
problems with your nervous system including involuntary muscle contractions (clonus); distorted sense of taste (dysgeusia); decrease in sense of taste (hypogeusia); decreased feeling of sensitivity, especially in the skin (hypoaesthesia); alteration in the nerve functions in the arms and legs (neuropathy peripheral); blood clot in the transverse sinus (transverse sinus thrombosis);
tegobe s v ašim živčanim sustavom koje uključuju nevoljno stezanje/kontrakcije mišića (klonus); poremećen osjet okusa (disgeuzija); smanjen osjet okusa (hipogeuzija); smanjen osjet (smanjena osjetljivost), osobito na koži (hipoestezija); promjene u funkciji živaca, poglavito u rukama i nogama (periferna neuropatija); krvni ugrušak u t ransverzalnom sinusu (tromboza transverzalnog sinusa);
problems with your nervous system including involuntary muscle contractions (clonus); distorted sense of taste (dysgeusia); decrease in sense of taste (hypogeusia); decreased feeling of sensitivity, especially in the skin (hypoaesthesia); alteration in the nerve functions in the arms and legs (neuropathy peripheral); blood clot in the transverse sinus (transverse sinus thrombosis);
tegobe s vašim živčanim sustavom koje uključuju nevoljno stezanje/kontrakcije mišića (klonus); poremećen osjet okusa (disgeuzija); smanjen osjet okusa (hipogeuzija); smanjen osjet (smanjena osjetljivost), osobito na koži (hipoestezija); promjene u funkciji živaca, poglavito u rukama i nogama (periferna neuropatija); krvni ugrušak u transverzalnom sinusu (tromboza transverzalnog sinusa);
problems with your parathyroid gland
problemi s paratireoidnom žlijezdom
problems with your parathyroid gland
problemi s paratiroidnom žlijezdom
Problems with your small blood vessels (capillaries) may develop (systemic capillary leak syndrome) when using medicines like Extavia.
Mogu se razviti problemi s malim krvnim žilama (kapilarama) kada se koriste lijekovi poput Extavije (sindrom povećane propusnosti sistemskih kapilara).
Problems with your small blood vessels (capillaries) may develop when using medicines like Betaferon (systemic capillary leak syndrome).
Problemi s Vašim malim krvnim žilama (kapilarama) mogu nastati prilikom uporabe lijekova kao što je Betaferon (sindrom povećane propusnosti sistemsih kapilara).
problems with your urine
problemi s mokraćom
Procainamide, used to treat cardiac arrhythmia.
prokainamidom - koristi se za liječenje srčane aritmije.
procedural
komplikacije
procedural
proceduralne
Procedural complication
proceduralna komplikacija
procedural complications
Ozljede, trovanja i proceduralne komplikacije
Procedural hypotension
proceduralna hipotenzija
Procedural pain
bol pri postupku
Procedural pain
bol prilikom postupka
Procedural site reaction
reakcija na mjestu zahvata
Procedure
Postupak:
Procedure for preparing vaccine suspension:
Priprema suspenzije cjepiva za injekciju:
Procedures for proper handling and disposal of anticancer medicinal products should be considered.
Moraju se slijediti postupci za pravilno rukovanje i odlaganje antitumorskih lijekova.
Procedures for proper handling and disposal of cytotoxic medicinal products must be followed.
Nužno je pridržavati se postupaka za ispravno rukovanje i odlaganje citotoksičnih lijekova.
Procedures for proper handling and disposal should be observed.
Treba se pridržavati postupaka za pravilno rukovanje i zbrinjavanje.
Proceed with subsequent planned dinutuximab and GM-CSF or IL-2 courses.
Nastaviti sa sljedećim planiranim ciklusima dinutuksimaba i GM-CSF-a ili IL-2.
Proceed with the infusion as quickly as possible, avoiding keeping the bag in the water bath after thawing.
Krenite s infuzijom što je prije moguće, izbjegavajući držanje vrećice u vodenoj kupelji nakon odmrzavanja.
Proceed with your next dose immediately and continue at regular intervals as advised by your doctor.
Odmah nastavite s primjenom sljedeće doze i nastavite u redovnim intervalima kako Vam je to savjetovao Vaš liječnik.
Proceed with your next dose immediately and continue at regular intervals as advised by your doctor.
Odmah uzmite sljedeću dozu te nastavite uzimati lijek u redovitim vremenskim razmacima koje Vam je odredio liječnik.
Process-specific impurities:
Nečistoće specifične za proces:
Procoralan (ivabradine) is a heart medicine used to treat:
Procoralan (ivabradin) je lijek za srce koji se primjenjuje u liječenju:
Procoralan 5 mg film-coated tablets ivabradine
Procoralan 5 mg filmom obložene tablete ivabradin
Procoralan 5 mg film-coated tablets Procoralan 7.5 mg film-coated tablets
Procoralan 5 mg filmom obložene tablete Procoralan 7,5 mg filmom obložene tablete
Procoralan 5 mg film-coated tablets Procoralan 7.5 mg film-coated tablets ivabradine
Procoralan 5 mg filmom obložene tablete Procoralan 7,5 mg filmom obložene tablete ivabradin
Procoralan 5 mg tablets are salmon-coloured, oblong film-coated tablets scored on both sides, engraved with “5” on one face and on the other.
Procoralan 5 mg tablete su duguljaste filmom obložene tablete boje lososa s razdjelnom crtom na obje strane, s utisnutom oznakom “5” na jednoj strani, a  na drugoj.
Procoralan 7.5 mg film-coated tablets ivabradine
Procoralan 7,5 mg filmom obložene tablete ivabradin
Procoralan 7.5 mg tablets are salmon-coloured, triangular, film-coated tablets engraved with “7.5” on one face and on the other.
Procoralan 7,5 mg tablete su trokutaste filmom obložene tablete boje lososa s utisnutom oznakom “7.5” na jednoj strani , a  na drugoj.
Procoralan has also been compared with placebo in one main study involving 6,558 patients with long- term moderate to severe heart failure.
Procoralan je također uspoređen s placebom u jednom glavnom ispitivanju koje je uključivalo 6.558 bolesnika s kroničnim umjerenim do ozbiljnim zatajenjem srca.
Procoralan has been studied in five main studies involving over 4,000 adults with long-term stable angina.
Procoralan se ispitivao u pet glavnih ispitivanja koja su obuhvatila više od 4 000 odraslih osoba s kroničnom stabilnom anginom.
Procoralan is a medicine that contains the active substance ivabradine.
Procoralan je lijek koji sadrži djelatnu tvar ivabradin.
Procoralan is also used in patients with long-term heart failure (when the heart cannot pump enough blood to the rest of the body) who have a normal heart rhythm but whose heart rate is at least 75 beats per minute.
Procoralan se također primjenjuje u bolesnika s kroničnim zatajenjem srca (kada srce ne može opskrbljivati ostatak tijela s dovoljno krvi), koji imaju normalni srčani ritam, no čija je srčana frekvencija najmanje 75 otkucaja po minuti.
Procoralan is not intended for use in children and adolescents younger than 18 years.
Procoralan nije namijenjen djeci ni adolescentima mlađima od 18 godina.
Procoralan is used to treat the symptoms of long-term stable angina (pains to the chest, jaw and back, brought on by physical effort) in adults with coronary artery disease (disease of the heart caused by the obstruction of the blood vessels that supply blood to the heart muscle) who have a normal heart rhythm.
Procoralan se koristi za simptomatsko liječenje kronične stabilne angine (boli u prsima, čeljusti i leđima, koja je uzrokovana fizičkim naporom) u odraslih osoba s koronarnom arterijskom bolesti (bolesti srca koju uzrokuje opstrukcija krvnih žila koje opskrbljuju srčani mišić krvlju) s normalnim srčanim ritmom.
Procoralan ivabradine
Procoralan ivabradin
Procoralan must not be used in patients who have a resting heart rate below 70 beats per minute, very low blood pressure, various types of heart disorder (including cardiogenic shock, rhythm disorders, heart attack, unstable or acute (sudden) heart failure and unstable angina) or severe liver problems.
Procoralan se ne smije koristiti u bolesnika koji imaju srčanu frekvenciju u mirovanju manju od 60 otkucaja po minuti, vrlo niski krvni tlak, različite tipove srčanog poremećaja (uključujući kardiogeni šok, poremećaj ritma, infarkt miokarda, nestabilno ili akutno (iznenadno) zatajenje srca i nestabilnu anginu) ili ozbiljne probleme s jetrom.
Procoralan was also more effective than placebo when added to atenolol.
Procoralan je bio djelotvorniji od placeba ako se dodao atenololu.
Procoralan with food and drink
Procoralan s hranom i pićem
Procox 0.9 mg/ml + 18 mg/ml oral suspension for dogs
Procox 0,9 mg/ml + 18 mg/ml peroralna suspenzija za pse
Procox 0.9 mg/ml + 18 mg/ml oral suspension for dogs
Procox 0,9 mg/ml+18 mg/ml peroralna suspenzija za pse
Procox 0.9 mg/ml + 18 mg/ml oral suspension for dogs emodepside/toltrazuril
Procox 0,9 mg/ml +18 mg/ml peroralna suspenzija za pse emodepsid/toltrazuril
Procox 0.9 mg/ml + 18 mg/ml oral suspension for dogs emodepside/toltrazuril
Procox 0,9 mg/ml+18 mg/ml peroralna suspenzija za pse emodepsid/toltrazuril
Procox is effective against the replication of coccidia and against the shedding of oocysts.
Procox je učinkovit protiv umnažanja kokcidija i protiv izlučivanja oocista.
Procox is effective against the replication of Isospora and also against the shedding of oocysts.
Procox je učinkovit protiv umnažanja Isospora i također protiv izlučivanja oocista.
Procox is not recommended to be used in dogs of Collie or related breeds that carry or are suspected to carry the mdr1 -/- mutation, because the tolerance of the product in mdr1 -/- mutant puppies has been shown to be lower than in other puppies.
Procox se ne preporučuje za primjenu kod pasa pasmine koli ili srodnih pasmina koje su nosioci mdr1-/- mutacije, jer je tolerancija proizvoda kod štenaca s mdr1-/- mutacijom dokazano niža nego kod drugih štenaca.
Procox is not recommended to be used in dogs of Collie or related breeds that carry or are suspected to carry the mdr1 -/- mutation, because the tolerance of the product in mdr1 -/- mutant puppies has been shown to be lower than in other puppies.
Procox se ne preporučuje za primjenu kod pasa pasmine koli ili srodnih pasmina koje su nosioci mdr1-/- mutacije, jer je tolerancija proizvoda kod štenaca sa mdr1-/- mutacijom dokazano niža nego kod drugih štenaca.
Procox oral suspension is supplied in two different pack sizes containing 7.5 or 20 ml.
Procox je peroralna suspenzija koja je dostupna u dvije različite veličine pakiranja koja sadržavaju 7,5 ili 20 ml.
proctitis, pancreatitis
proktitis, pankreatitis
proctitisd
proktitisd
PROCYSBI 25 mg gastro-resistant hard capsules
PROCYSBI 25 mg želučanootporne tvrde kapsule
PROCYSBI 25 mg gastro-resistant hard capsules Cysteamine
PROCYSBI 25 mg želučanootporne tvrde kapsule cisteamin
PROCYSBI 25 mg is presented as blue gastro-resistant hard capsules.
PROCYSBI 25 mg je u obliku plavih tvrdih želučanootpornih kapsula.
PROCYSBI 75 mg gastro-resistant hard capsules
PROCYSBI 75 mg želučanootporne tvrde kapsule
PROCYSBI 75 mg gastro-resistant hard capsules Cysteamine
PROCYSBI 75 mg želučanootporne tvrde kapsule cisteamin
PROCYSBI can be taken with sodas once degasified.
PROCYSBI se može uzimati uz bezalkoholna slatka pića kad ne sadrže plin.
Procysbi is a ‘hybrid medicine’.
Procysbi je „hibridni lijek”.
PROCYSBI is indicated for the treatment of proven nephropathic cystinosis.
PROCYSBIje indiciran za liječenje dokazane nefropatske cistinoze.
PROCYSBI should not be administered with food rich in fat or proteins, or with frozen food like ice- cream.
PROCYSBI se ne smije uzimati uz hranu bogatu proteinima ili uz smrznutu hranu kao što je sladoled.
Prodivet ZN, Nutrição e Comércio de Produtos Químicos, Farmacêuticos e Cosméticos, S.A. Av.
Prodivet ZN, Nutrição e Comércio de Produtos Químicos, Farmacêuticos e Cosméticos, S.A.
Produced from porcine intestinal mucosa.
Proizvedeno iz sluznice svinjskog crijeva.
Produced in chick embryo cells.
Umnožen na stanicama pilećeg embrija.
produced in Escherichia coli by recombinant DNA technology.
proizveden tehnologijom rekombinantne DNK u bakteriji Escherichia coli.
Produced in human diploid (MRC-5) cells.
Umnožen na ljudskim diploidnim (MRC-5) stanicama.
Produced in human diploid cells (MRC-5).
Umnožen na (MRC-5) ljudskim diploidnim stanicama.
Produced in human diploid lung (WI-38) fibroblasts.
Umnožen na (WI-38) ljudskim diploidnim fibroblastima pluća.
Produced in human diploid lung (WI-38) fibroblasts.
Umnožen na ljudskim diploidnim plućnim (WI-38) fibroblastima.
produced in Saccharomyces cerevisiae (strain 2150-2-3) yeast by recombinant DNA technology.
proizvedeno u kvascu Saccharomyces cerevisiae (soj 2150-2-3) tehnologijom rekombinantne DNA.
produced in Vero cells
proizveden na Vero stanicama
producing less urine than normal muscle spasms.
tvaranje manje mokraće nego što je to uobičajeno grčevi u mišićima.
Producing more tears
pojačano suzenje
producing more tears, tear duct problems, inflamed eye (conjunctivitis)
pojačano suzenje, tegobe sa suznim kanalima, upala oka (konjunktivitis)
Product Application
Primjena proizvoda
Product Application (see Figure 4):
Primjena proizvoda (vidi Prikaz 4):
Product description
opis lijeka
Product in the unopened bottle and sachet, stored in the outer carton, is stable at temperatures up to 25oC for a period of 14 days.
Proizvod u neotvorenoj boci i vrećici, čuvan u vanjskoj kutiji, stabilan je pri temperaturama do 25C u razdoblju od 14 dana.
Product information (SPC)
Informacije o lijeku (Sažetak opisa svojstava lijeka)
Product information (Summary of Product Characteristics (SmPC) and Package Leaflet)
Informacije o lijeku (sažetak opisa svojstava lijeka (SPC) i uputu o lijeku)
Product information (summary of product characteristics, patient information leaflet and patient alert card)
Informacije o lijeku (sažetak opisa svojstava lijeka, uputa o lijeku i kartica s upozorenjima za bolesnika)
Product Manufacturer:
Proizvođač
Product preparation
Priprema lijeka
Product strength (micrograms)
Jačina lijeka (mikrogrami)
Product taste abnormal
nenormalan okus lijeka
Product with particulate matter or discoloration should not be used.
Ako lijek sadrži vidljive čestice ili je promijenio boju, ne smije se primijeniti.
Product-class-related adverse reactions
Nuspojave vezane uz skupinu kojoj lijek pripada
Product-specific data can be evaluated during signal work-up.
Podaci specifični za cjepivo procjenjivat će se tijekom obrade signala.
Product-specific data can be evaluated during signal work-up.
Podaci vezani za određeni proizvod mogu se procjenjivati tijekom postupka otkrivanja signala.
Production of beta-lactamases that can hydrolyse ceftolozane and which are not inhibited by tazobactam (see below)
proizvodnju beta-laktamaza koje mogu hidrolizirati ceftolozan i koje ne inhibira tazobaktam (vidjeti u nastavku) modifikaciju PBP-ova.
Production of much more or much less urine than usual (which may be a symptom of kidney failure), passing blood in the urine
tvaranje mnogo veće ili mnogo manje količine mokraće nego što je uobičajeno (što može biti simptom zatajenja bubrega), krv u mokraći
production of red blood cells); this causes severe anaemia, symptoms of which would include unusual tiredness and a lack of energy,
To uzrokuje tešku anemiju čiji simptomi uključuju neuobičajeni umor i manjak energije,
Production Site Oranienburg Lehnitzstrasse 70-98
Proizvodno mjesto Oranienburg Lehnitzstrasse 70-98
Production site Oranienburg Lehnitzstraße 70-98
Proizvodno mjesto Oranienburg Lehnitzstraße 70-98
Production site Oranienburg Lehnitzstraße 70-98
Proizvodno mjesto Oranienburg Lehnitzstraβe 70-98
Production site Oranienburg Lehnitzstraße 70-98, 16515 Oranienburg Germany
Proizvodno mjesto Oranienburg Lehnitzstrasse 70-98, 16515 Oranienburg Njemačka
productive cough, wheezing or exertional or exacerbated shortness of breath
kašalj s iskašljavanjem, piskanje ili gubitak daha u naporu ili pogoršanje nedostatka daha
Products containing calcium and other multivalent cations (such as aluminium, magnesium, iron), including milk and food, are likely to interfere with absorption of Iasibon tablets.
Proizvodi koji sadrže kalcij i ostale multivalentne katione (kao što su aluminij, magnezij i željezo), uključujući mlijeko i hranu, mogu utjecati na apsorpciju tableta lijeka Iasibon.
Products containing ketoconazole (against fungal infections), macrolide antibiotics, or diltiazem (treatment for high blood pressure and chest pain) may increase the effects of Samsca.
Lijekovi koji sadrže ketokonazol (protiv gljivičnih infekcija), makrolidni antibiotici ili diltiazem (lijek za visoki krvni tlak i bol u prsištu) mogu pojačati djelovanje Samsce.
products may be increased when
povećati kada se primjenjuju istodobno s
PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE
OTPADNIH MATERIJALA KOJI POTJEČU OD LIJEKA, AKO JE POTREBNO
Produlab Pharma B.V. Forellenweg 16
Forellenweg 16
Profender 15 mg / 3 mg modified-release Tablets for Small Dogs
Profender 15 mg/ 3 mg tablete s prilagođenim otpuštanjem za male pse
Profender 15 mg / 3 mg modified-release Tablets for Small Dogs
Profender 15 mg/3 mg tablete s prilagođenim otpuštanjem za male pse
Profender 15 mg / 3 mg Tablets for Small Dogs Blister
Profender 15 mg/3 mg tablete za male pse blister
Profender 15 mg/3 mg modified-release Tablets for Small Dogs Profender 50 mg/10 mg modified-release Tablets for Medium Dogs Profender 150 mg/30 mg modified-release Tablets for Large Dogs
Profender 15 mg/3 mg tablete s prilagođenim otpuštanjem za male pse Profender 50 mg/10 mg tablete s prilagođenim otpuštanjem za srednje velike pse Profender 150 mg/30 tablete s prilagođenim otpuštanjem za velike pse
Profender 15 mg/3 mg modified-release Tablets for Small Dogs Profender 50 mg/10 mg modified-release Tablets for Medium Dogs Profender 150 mg/30 mg modified-release Tablets for Large Dogs
Profender 15 mg/3mg tablete s prilagođenim otpuštanjem za male pse Profender 50 mg/10mg tablete s prilagođenim otpuštanjem za srednje velike pse Profender 150 mg/30mg tablete s prilagođenim otpuštanjem za velike pse
Profender 150 mg / 30 mg modified-release Tablets for Large Dogs
Profender 150 mg/ 30 mg tablete s prilagođenim otpuštanjem za velike pse
Profender 150 mg / 30 mg Tablets for Large Dogs Blister
Profender 150 mg/30 mg tablete za velike pse blister
Profender 150 mg / 30 mg Tablets for Large Dogs Outer carton, pack size of 2 tablets
Profender 150 mg/ 30 mg tablete za velike pse Vanjsko pakovanje, veličina pakovanja 2 tablete
Profender 30 mg / 7.5 mg spot-on solution for small cats Profender 60 mg / 15 mg spot-on solution for medium cats Profender 96 mg / 24 mg spot-on solution for large cats
Profender 30 mg / 7,5 mg spot-on otopina za male mačke Profender 60 mg / 15 mg spot-on otopina za srednje velike mačke Profender 96 mg / 24 mg spot-on otopina za velike mačke
Profender 30 mg/7.5 mg spot-on solution for small cats Profender 60 mg/15 mg spot-on solution for medium cats Profender 96 mg/24 mg spot-on solution for large cats
Profender 30 mg/7,5 mg spot-on otopina za male mačke Profender 60 mg/15 mg spot-on otopina za srednje velike mačke Profender 96 mg/24 mg spot-on otopina za velike mačke
Profender 50 mg / 10 mg modified-release Tablets for Medium Dogs
Profender 50 mg/ 10 mg tablete s prilagođenim otpuštanjem za srednje velike pse
Profender 50 mg / 10 mg modified-release Tablets for Medium Dogs
Profender 50 mg/10 mg tableta s prilagođenim otpuštanjem za srednje velike pse
Profender 50 mg / 10 mg Tablets for Medium Dogs Blister
Profender 50 mg/10 mg tablete za srednje velike pse blister
Profender 50 mg / 10 mg Tablets for Medium Dogs Outer carton, pack size of 2 (or 4) tablets
Profender 50 mg/ 10 mg tablete za srednje velike pse Vanjsko pakovanje, veličina pakovanja 2 (ili 4) tablete
Profender 50 mg / 10 mg Tablets for Medium Dogs Outer carton, pack size of 6 (24 or 102) tablets
Profender 50 mg/ 10 mg tablete za srednje velike pse Vanjsko pakovanje, veličina pakovanja 6 (24 ili 102) tableta
Profender 60 mg/15 mg spot-on solution for medium cats
Profender 60 mg/15 mg spot-on otopina za srednje velike mačke
Profender 60 mg/15 mg spot-on solution for medium cats
Profender spot-on otopina za srednje velike mačke
Profender 85.8 mg/ml / 21.4 mg/ml spot-on solution for cats
Profender 85,8 mg/ml / 21,4 mg/ml spot-on otopina za mačke
Profender 85.8 mg/ml / 21.4 mg/ml spot-on solution for cats Praziquantel/Emodepside
Profender 85,8 mg/ml / 21,4 mg/ml spot-on otopina za mačke Prazikvantel/emodepsid
Profender 96 mg/24 mg spot-on solution for large cats
Profender 96 mg/24 mg spot-on otopina za velike mačke
Profender can be used during pregnancy and lactation.
Profender se može primjenjivati tijekom gravidnosti i laktacije.
Profender contains 21.4 mg/ml emodepside and 85.8 mg/ml praziquantel.
Profender sadržava 21,4 mg/ml emodepsida i 85,8 mg/ml prazikvantela
Profender for cats (> 2.5–5 kg)
Profender za mačke (>2,5 kg – 5 kg)
Profender for cats (> 5–8 kg)
Profender za mačke (>5 kg – 8 kg)
Profender for cats ( 0.5–2.5 kg)
Profender za mačke (≥0,5 kg – 2,5 kg)
Profender for Large Cats
Profender Spot-on za velike mačke
Profender for Large Cats (> 5 – 8 kg)
Profender za velike mačke (> 5 – 8 kg)
Profender for Medium Cats
Profender Spot-on za srednje velike mačke
Profender for Medium Cats (> 2.5 – 5 kg)
Profender sa srednje velike mačke (> 2,5 – 5 kg)
Profender for Small Cats
Profender Spot-on za male mačke
Profender for Small Cats ( 0.5 - 2.5 kg)
Profender za male mačke ( 0,5 - 2,5 kg)
Profender for Small Cats ( 0.5 - 2.5 kg)
Profender za male mačke ( 0,5 – 2,5 kg)
Profender should not be allowed to enter water courses as emodepside has shown harmful effects on aquatic organisms.
Profender ne bi smio dospjeti u vodotoke jer je emodepsid pokazao štetno djelovanje na organizme vodenih ekosustava.
Profender should not be allowed to enter water courses as emodepside has shown harmful effects on aquatic organisms.
Profender ne bi trebao dospjeti u vodotoke jer je emodepsid pokazao štetno djelovanje na organizme vodenih ekosustava.
Profender should not be used for any other animal species.
Profender se ne smije koristiti za druge životinjske vrste.
Profender spot-on solution for cats
Profender spot-on otopina za mačke
Profender spot-on solution for cats Bottle label
Profender spot-on otopina za mačke Etiketa na bočici
Profender spot-on solution for cats Outer carton, Multi-dose bottle
Profender spot-on otopina za mačke Vanjsko pakovanje, bočica sa više doza
Profender spot-on solution for large cats
Profender spot-on otopina za velike mačke
Profender spot-on solution for large cats (> 5-8 kg)
Profender spot-on otopina za velike mačke (>5 kg – 8 kg)
Profender spot-on solution for large cats blister
Profender spot-on otopina za velike mačke blister
Profender spot-on solution for large cats Pipette label
Profender spot-on otopina za velike mačke Etiketa na pipeti
Profender spot-on solution for medium cats
Profender spot-on otopina za srednje velike mačke
Profender spot-on solution for medium cats (>2.5-5 kg)
Profender spot-on otopina za srednje velike mačke (≥2,5 kg – 5 kg)
Profender spot-on solution for medium cats blister
Profender spot-on otopina za srednje velike mačke blister